moderna stock price target
MRNA was reported by JP Morgan on October 24 2022The analyst firm set a price target for 12200 expecting MRNA to fall to. Find the latest Moderna Inc.
Moderna Stock Is Still A Winner Goldman Sachs Says Barron S
Based on 11 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months.
. SVB Leerink raised Moderna from an underperform rating to a market perform rating and reduced their price target for the stock from 17400 to 10100 in a report on. The average price target is 20080 with a high forecast of 50600 and a low. According to 25 stock analysts the average 12-month stock price forecast for Moderna stock is 22221 which predicts an increase of 68.
The 13 analysts offering 12-month price forecasts for Moderna Inc have a median target of 17500 with a high estimate of 50600 and a low estimate of 10100. Shares of NASDAQMRNA opened at 15097 on Friday. The latest price target for.
MRNA updated stock price target summary. Moderna Stock Forecast 2022. BioNTech stock price target cut to 132 from 183 at JP.
Shares of NASDAQMRNA opened at 13409 on Tuesday. Target Price consensus revisions. NASDAQMRNA traded at 15097 at close of the session on Friday 102822 made an upward move of 476 on its previous days price.
On average they anticipate the. Modernas current and average target prices are 15097 and 25723 respectively. Their MRNA share price forecasts range from 10100 to 30400.
View real-time stock prices and stock quotes for a full financial overview. Moderna stock price is down 288 at last trading dayModerna stock price increased from 14450 to 14434. Moderna stock price target cut to 122 from 165 at JP.
Has a 12 month low of 11503 and a 12 month high of 37665. On the other hand. Assess the Moderna stock price estimates.
Evolution of the average Target Price on MODERNA INC. Moderna Stock Price Target. Morgan MarketWatch 1321 Amgen stock price target raised to 265 from 227 at JP.
Based on short-term price targets offered by 12 analysts the average price target for Moderna comes to 23042. Moderna Stock Down 37. Analyst ratings historical stock prices earnings estimates actuals.
Based on 13 analysts offering 12 month price targets for Moderna Inc. Moderna came into the week with some positive momentum after fellow drugmaker Pfizer PFE 369 announced plans to raise the price of its COVID-19 vaccine next year to as. Moderna NASDAQMRNA Get Rating had its price target decreased by Cowen from 16500 to 14500 in a report released on Thursday morning Stock Target Advisor.
13 brokerages have issued 12-month target prices for Modernas shares. Last 18 months Recommendations Chart MODERNA INC. The stock has a market cap of 6005.
View analyst opinion as to whether the stock is a strong buy strong sell or hold based on analyst 12-Month MRNA price targets. MRNA stock quote history news and other vital information to help you with your stock trading and investing. Stock Price Forecast.
Be the first to. 24 2022 at 722 am. Morgan MarketWatch.
The forecasts range from a low of 7400 to a high of 50600. Finally Morgan Stanley decreased their target price on shares of Moderna from 19900 to 19700 and set an equal weight rating on the stock in a research report on. The current price of Moderna is the price at which Moderna is currently trading.
The company has a market capitalization of 5334 billion a PE ratio of 409 a price.
Where Will Moderna Be In 1 Year The Motley Fool
Global Markets Fall After Moderna Omicron Warning Bbc News
8 Newly Undervalued 5 Star Stocks Morningstar
Pfizer And Moderna Raise Eu Covid Vaccine Prices Financial Times
Moderna Stock Extends Rally After Price Target Gets A 77 Boost At Morgan Stanley Marketwatch
Why Novavax Is Outperforming Moderna Nasdaq Nvax Seeking Alpha
Moderna Crash Wipes Out Over 20 Billion In Market Value After Concerns Stock Is Overhyped
Moderna Stock Forecast Mrnaprediction For 2022 2023 2025 And 2026 2030 Libertex Com
Moderna S Stock Price Is Ridiculous Says Bofa Analyst Marketwatch
Moderna2021proxystatement
Moderna Executives Sell Stock As Coronavirus Vaccine Boosts Company Shares The Washington Post
Moderna Stock Nasdaq Mrna Focus On Possibilities Not Politics
Moderna Pipeline Development Is The Key In 2022 Says Morgan Stanley Nasdaq
Moderna Stock Extends Rally After Price Target Gets A 77 Boost At Morgan Stanley Marketwatch
Moderna Stock Is A Speculative Buy On Covid 19 Vaccine Success Nasdaq Mrna Seeking Alpha
These 2 Growth Stocks Have Fallen Out Of Grace Are They Buys The Motley Fool
Moderna Ceo S Comments Jolt Markets Business And Economy News Al Jazeera
Moderna Biontech Rally Stalls Ahead Of Cdc Meeting On Boosters Bnn Bloomberg
Stocks These Are The Stocks To Watch As Covid Enters Its Next Phase The Economic Times